SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003295
Filing Date
2022-11-14
Accepted
2022-11-14 09:50:22
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fwbi-20220930x10q.htm   iXBRL 10-Q 2423879
2 EX-31.1 fwbi-20220930xex31d1.htm EX-31.1 12516
3 EX-31.2 fwbi-20220930xex31d2.htm EX-31.2 12535
4 EX-32.1 fwbi-20220930xex32d1.htm EX-32.1 8062
  Complete submission text file 0001410578-22-003295.txt   9155942

Data Files

Seq Description Document Type Size
5 EX-101.SCH fwbi-20220930.xsd EX-101.SCH 86581
6 EX-101.CAL fwbi-20220930_cal.xml EX-101.CAL 51137
7 EX-101.DEF fwbi-20220930_def.xml EX-101.DEF 300545
8 EX-101.LAB fwbi-20220930_lab.xml EX-101.LAB 634047
9 EX-101.PRE fwbi-20220930_pre.xml EX-101.PRE 471590
68 EXTRACTED XBRL INSTANCE DOCUMENT fwbi-20220930x10q_htm.xml XML 1341422
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 221381426
SIC: 2834 Pharmaceutical Preparations